← MyLongPath

SS-31

Medication0 reviews
Average score out of 5

Experimental peptide that binds to cardiolipin in the inner mitochondrial membrane to improve mitochondrial function and reduce oxidative stress. Investigated in Long COVID for fatigue and cellular energy dysfunction.

Information
Subcategory
mitochondria-targeted peptide
Evidence type
preclinical and early clinical trials
Share your experience

Your feedback helps thousands of people find what really works.

Join the community